582 Companies
PAR Technology Corporation, a leading provider of innovative technology solutions to the restaurant and retail industries globally, is divided into two segments: Restaurant/Retail and Government. W...
PAR Annual Report 2023Cambridge-based biotech company Moderna, Inc. has made a name for itself in the field of messenger RNA (mRNA) therapeutics and vaccines. The company's products target a range of medical issues incl...
Moderna Annual Report 2023Theravance Biopharma, a prominent biopharmaceutical firm, has been making waves with its groundbreaking respiratory medicines, which are developed and distributed across the United States and Europ...
Theravance Biopharma Annual Report 2023BioCryst Pharmaceuticals, Inc., a leading biotechnology company headquartered in Durham, North Carolina, has made significant strides in the field of small-molecule medicines. With a focus on disco...
BioCryst Pharmaceuticals Annual Report 2023Motus GI Holdings, Inc., a US-based medical technology company, has reportedly developed a groundbreaking medical device that promises to revolutionize the gastrointestinal (GI) tract cleansing pro...
Motus GI Annual Report 2023China Biologic Products, Inc. (NASDAQ: CBPO) is a prominent Chinese biopharmaceutical company that specializes in plasma-based therapies. The company's products are widely used for emergency medica...
China Biologic Products, Inc. Annual Report 2018EyePoint Pharmaceuticals Aiming to Enhance Lives of Patients with Serious Eye Disorders EyePoint Pharmaceuticals, Inc. is a United States-based pharmaceutical company dedicated to developing and c...
EyePoint Pharmaceuticals Annual Report 2023Tyme Technologies, Inc. is a biotech firm that is focused on developing cancer metabolism-based treatments that have low toxicity and can be effective for various kinds of tumors. The firm's approa...
Tyme Annual Report 2021Seres Therapeutics, a company focused on microbiome therapeutics, is working to develop a unique class of biological drugs for the modulation of the colonic microbiome. The company's lead candidate...
Seres Therapeutics Annual Report 2023Aptevo Therapeutics Inc., a clinical-stage biotechnology company, is working on developing immunotherapeutic candidates in the United States for various types of cancer. Its lead clinical candidate...
Aptevo Therapeutics Inc. Annual Report 2023IGM Biosciences, a clinical-stage biotech firm, is on a mission to produce Immunoglobulin M (IgM) antibodies that may help fight cancer, infectious diseases, as well as autoimmune and inflammatory ...
IGM Biosciences Annual Report 2023San Francisco, CA - 89bio, Inc., a clinical-stage biopharmaceutical company with a laser focus on delivering cutting-edge therapies for liver and cardio-metabolic diseases, is making waves. The com...
89Bio Annual Report 2023Corcept Therapeutics Incorporated, a California-based company, has been making waves in the drug discovery and development industry. The firm specializes in curing severe metabolic, oncologic, endo...
Corcept Therapeutics Annual Report 2023iBio, Inc., a Texas-based biotechnology company, is making strides in the development and manufacturing of biopharmaceuticals as well as vaccine and therapeutic candidates for a variety of diseases...
iBio Annual Report 2023Zymeworks, a Vancouver-based clinical-stage biopharmaceutical company, has made significant progress in the development and commercialization of biotherapeutics for cancer treatment. The company's ...
Zymeworks Annual Report 2023